Trials / NCT05294978
EyeConic: Qualification for Cone-Optogenetics
Recruiting now Observational Natural history / observational
- Sponsor
- Institute of Molecular and Clinical Ophthalmology Basel
- Treatment
- Optical coherence tomography (OCT)
- Gene
- Not gene-specific
- Conditions
- Retinal Dystrophies
- Ages
- Any to no upper limit
- Enrollment
- 1000 participants
- Started
- 2021-07-01
- Main results expected
- 2026-12
- Results posted
- Not yet
- Record last updated
- 2025-07-31
What the study is testing
This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.
Where it runs
China (1)
- Beijing Institute of Ophthalmology, Beijing (recruiting now)
Germany (1)
- Universitätsklinikum Tübingen Augenklinik, Tübingen (recruiting now)
Hungary (1)
- Semmelweis University, Department of Ophthalmology, Budapest (recruiting now)
Italy (1)
- Oculista Ospedale Parma, Parma (recruiting now)
Switzerland (1)
- University Hospital Basel, Eye Clinic, Basel (recruiting now)
United Kingdom (1)
- Moorfields Eye Hospital, London (recruiting now)
United States (3)
- University of California San Francisco, Department of Ophthalmology, San Francisco, California (recruiting now)
- Bascom Palmer Eye Institute, Miami, Florida (recruiting now)
- University of Pittsburgh, Department of Ophthalmology, Pittsburgh, Pennsylvania (recruiting now)